IMU 5.56% 5.7¢ imugene limited

Media Thread, page-7619

  1. 3,176 Posts.
    lightbulb Created with Sketch. 6845
    Well worth 2nd viewing. We’ve got 4 presentations at the Gastric Cancer Conference. Which includes Pembrolizumab (Keytruda)/HerVAX combo. Then on top of that they are presenting VACCINIA in Gastric Cancer , 4 presentations in all.

    This week we will see the first CheckVax patient data. The Last announcement for CheckVax was first patient in cohort 2 dosed on 13/4 . Nearly 8 months ago. They initially told us this trial had patients lined up and eager to go. So they’ve definitely had time to see some signs of efficacy.

    It gets really interesting when LC talks about being invited to the JP MORGAN Biotech conference. She doesn’t tell us what she is presenting on. It appears she is introducing IMUGENE to the big biotech world. Then at 5.25 mark she talks about taking our place with the big biotech companies.

    So she’s been in the US talking to JP Morgan and they want to introduce her and IMUGENE to the industry leaders in the biotech world. They are the royalty. They’ve got the prestige, power and money to really make things happen,

    Any other ASX Biotech would sell their first born to be up on stage at JP Morgan.

    After this presentation we really will have everybody’s attention.
 
watchlist Created with Sketch. Add IMU (ASX) to my watchlist
(20min delay)
Last
5.7¢
Change
0.003(5.56%)
Mkt cap ! $417.2M
Open High Low Value Volume
5.5¢ 5.8¢ 5.2¢ $2.499M 45.00M

Buyers (Bids)

No. Vol. Price($)
2 1921794 5.6¢
 

Sellers (Offers)

Price($) Vol. No.
5.7¢ 1368288 7
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
IMU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.